Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Inv. presentation
Auditor change
|
|
Cellular Biomedicine Group, Inc. (CBMG)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/19/2021 |
4
| Au Chun Kwok Alan (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Disposed/sold 4,000 options to buy
@ $15.62, valued at
$62.5k
Disposed/sold 5,056 options to buy
@ $20, valued at
$101.1k
Disposed/sold 2,060 options to buy
@ $20, valued at
$41.2k
Disposed/sold 9,789 options to buy
@ $13.35, valued at
$130.7k
Disposed/sold 12,056 options to buy
@ $10.8, valued at
$130.2k
Disposed/sold 7,213 options to buy
@ $19.71, valued at
$142.2k
Disposed/sold 2,238 options to buy
@ $17, valued at
$38k
Disposed/sold 1,390 options to buy
@ $17.89, valued at
$24.9k
Disposed/sold 6,348 options to buy
@ $0 |
|
| 02/19/2021 |
4
| Ji Gang Jacky (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Disposed/sold 3,620 options to buy
@ $14.7, valued at
$53.2k
Disposed/sold 4,926 options to buy
@ $10.8, valued at
$53.2k
Disposed/sold 2,947 options to buy
@ $19.71, valued at
$58.1k
Disposed/sold 3,133 options to buy
@ $17, valued at
$53.3k
Disposed/sold 5,543 options to buy
@ $0 |
|
| 02/19/2021 |
4
| Belmont Terry (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Disposed/sold 3,000 options to buy
@ $15.62, valued at
$46.9k
Disposed/sold 4,000 options to buy
@ $12.94, valued at
$51.8k
Disposed/sold 8,761 options to buy
@ $20, valued at
$175.2k
Disposed/sold 11,895 options to buy
@ $13.35, valued at
$158.8k
Disposed/sold 14,648 options to buy
@ $10.8, valued at
$158.2k
Disposed/sold 8,765 options to buy
@ $19.71, valued at
$172.8k
Disposed/sold 6,944 options to buy
@ $17, valued at
$118k
Disposed/sold 6,348 options to buy
@ $0 |
|
| 02/19/2021 |
4
| Zhou Hansheng (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Disposed/sold 5,300 options to buy
@ $16, valued at
$84.8k
Disposed/sold 12,056 options to buy
@ $10.8, valued at
$130.2k
Disposed/sold 7,213 options to buy
@ $19.71, valued at
$142.2k
Disposed/sold 6,019 options to buy
@ $17, valued at
$102.3k
Disposed/sold 6,976 options to buy
@ $0 |
|
| 02/19/2021 |
4
| Schafer Edward T (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Disposed/sold 5,044 options to buy
@ $14.93, valued at
$75.3k
Disposed/sold 4,983 options to buy
@ $0 |
|
| 02/19/2021 |
4
| Liu Wen Tao (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Disposed/sold 213,076 shares
@ $0
Disposed/sold 146,667 options to buy
@ $3, valued at
$440k
Disposed/sold 5,477 options to buy
@ $17, valued at
$93.1k
Disposed/sold 6,348 options to buy
@ $0 |
|
| 02/19/2021 |
4
| Yao Yihong (Chief Scientific Officer) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 54,000 shares
@ $0
Disposed of 88,549 shares
@ $0
Disposed/sold 18,900 shares
@ $0
Disposed of 25,000 options to buy
@ $26.53, valued at
$663.3k
Disposed of 10,000 options to buy
@ $18.61, valued at
$186.1k
Disposed of 26,500 options to buy
@ $12.4, valued at
$328.6k
|
|
| 02/19/2021 |
4
| Chan Andrew K (Ch Legal Ofr, Corp Dev & Sec) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 48,000 shares
@ $0
Disposed/sold 239,747 shares
@ $0
Disposed/sold 38,880 options to buy
@ $3, valued at
$116.6k
Disposed/sold 37,904 options to buy
@ $5.61, valued at
$212.6k
Disposed of 15,000 options to buy
@ $18.61, valued at
$279.2k
Disposed/sold 15,000 options to buy
@ $12.55, valued at
$188.3k
Disposed/sold 23,000 options to buy
@ $12.4, valued at
$285.2k
|
|
| 02/19/2021 |
4
| Liu Tony (CEO, CFO) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 240,000 shares
@ $0
Disposed of 476,817 shares
@ $0
Disposed/sold 10,700 shares
@ $0
Disposed of 5,300 options to buy
@ $7.23, valued at
$38.3k
Disposed of 255,000 options to buy
@ $5, valued at
$1.3M
Disposed of 15,000 options to buy
@ $20.63, valued at
$309.5k
Disposed of 105,800 options to buy
@ $15.53, valued at
$1.6M
Disposed of 30,000 options to buy
@ $35.53, valued at
$1.1M
Disposed of 40,000 options to buy
@ $20, valued at
$800k
Disposed of 30,000 options to buy
@ $12.55, valued at
$376.5k
Disposed of 120,000 options to buy
@ $12.4, valued at
$1.5M
|
|
| 04/28/2020 |
4
| Au Chun Kwok Alan (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 6,348 options to buy
@ $14.65, valued at
$93k
|
|
| 04/28/2020 |
4
| Belmont Terry (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 6,348 options to buy
@ $14.65, valued at
$93k
|
|
| 04/28/2020 |
4
| Ji Gang Jacky (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 5,543 options to buy
@ $14.65, valued at
$81.2k
|
|
| 04/28/2020 |
4
| Liu Wen Tao (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 6,348 options to buy
@ $14.65, valued at
$93k
|
|
| 04/28/2020 |
4
| Schafer Edward T (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 4,983 options to buy
@ $14.65, valued at
$73k
|
|
| 04/28/2020 |
4
| Zhou Hansheng (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 6,976 options to buy
@ $14.65, valued at
$102.2k
|
|
| 10/15/2019 |
4
| Schafer Edward T (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 5,044 options to buy
@ $14.93, valued at
$75.3k
|
|
| 05/22/2018 |
4
| Hau Bosun (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 4,499 options to buy
@ $19.71, valued at
$88.7k
|
|
| 05/22/2018 |
4
| Au Chun Kwok Alan (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 7,213 options to buy
@ $19.71, valued at
$142.2k
|
|
| 05/22/2018 |
4
| Patel Nadir (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 5,152 options to buy
@ $19.71, valued at
$101.5k
|
|
| 05/22/2018 |
4
| Belmont Terry (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 8,765 options to buy
@ $19.71, valued at
$172.8k
|
|
| 05/22/2018 |
4
| Ji Gang Jacky (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 2,947 options to buy
@ $19.71, valued at
$58.1k
|
|
| 05/22/2018 |
4
| Zhou Hansheng (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 7,213 options to buy
@ $19.71, valued at
$142.2k
|
|
| 04/12/2018 |
4
| Liu Wen Tao (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Sold 10,400 shares
@ $20.095, valued at
$209k
Sold 12,044 shares
@ $20.08, valued at
$241.8k
Exercised 10,400 options to buy
@ $15.53, valued at
$161.5k
Exercised 12,044 options to buy
@ $15.53, valued at
$187k
|
|
| 03/13/2018 |
4
| Hau Bosun (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 285 options to buy
@ $19.35, valued at
$5.5k
|
|
| 12/27/2017 |
4
| Yao Yihong (Chief Scientific Officer) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Bought 4,167 shares
@ $12, valued at
$50k
|
|
| 12/27/2017 |
4
| Liu Tony (CEO, CFO) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Bought 29,167 shares
@ $12, valued at
$350k
|
|
| 12/27/2017 |
4
| Chan Andrew K (SVP Corp Bus Dev and Secretary) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Bought 8,333 shares
@ $12, valued at
$100k
|
|
| 06/07/2017 |
4
| Liu Tony (CEO, CFO) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Bought 800 shares
@ $6.81, valued at
$5.4k
Bought 100 shares
@ $6.78, valued at
$678
Bought 2,000 shares
@ $6.83, valued at
$13.7k
Bought 2,100 shares
@ $6.84, valued at
$14.4k
Bought 100 shares
@ $6.85, valued at
$685
Bought 800 shares
@ $6.8, valued at
$5.4k
Bought 1,200 shares
@ $6.84, valued at
$8.2k
Bought 2,900 shares
@ $6.85, valued at
$19.9k
|
|
| 05/05/2017 |
4
| Yao Yihong (Chief Scientific Officer) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Paid exercise price by delivering 199 shares
@ $10.7, valued at
$2.1k
|
|
| 04/03/2017 |
4
| Yao Yihong (Chief Scientific Officer) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 26,500 shares
@ $0
Granted 26,500 options to buy
@ $12.4, valued at
$328.6k
|
|
| 04/03/2017 |
4
| Liu Tony (CFO) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 120,000 shares
@ $0
Paid exercise price by delivering 975 shares
@ $11.4, valued at
$11.1k
Granted 30,000 options to buy
@ $12.55, valued at
$376.5k
Granted 120,000 options to buy
@ $12.4, valued at
$1.5M
|
|
| 04/03/2017 |
4
| Chan Andrew K (SVP Corp Bus Dev) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Granted 23,000 shares
@ $0
Granted 15,000 options to buy
@ $12.55, valued at
$188.3k
Granted 23,000 options to buy
@ $12.4, valued at
$285.2k
|
|
| 04/14/2016 |
4
| Cao Wei (William) (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Sold 10,000 shares
@ $17.15, valued at
$171.5k
Exercised 10,000 options to buy
@ $5.4, valued at
$54k
|
|
| 03/04/2016 |
4
| Cao Wei (William) (Director) has filed a Form 4 on Cellular Biomedicine Group, Inc.|
Txns:
| Sold 7,500 shares
@ $17.55, valued at
$131.6k
Exercised 7,500 options to buy
@ $5.4, valued at
$40.5k
|
|
|
|
|